| Line Item | 2026-02-01 | Y/Y |
|---|---|---|
| Revenue | $697.1M | +2.4% |
| Cost of Revenue | $303.9M | +7.5% |
| Gross Profit | $393.2M | -1.2% |
| R&D Expense | $7.0M | -16.7% |
| SG&A Expense | $284.0M | +0.9% |
| Operating Income | $5.4M | -60.7% |
| Pre-tax Income | $6.7M | -59.5% |
| Income Tax | $2.6M | -46.9% |
| Net Income | $4.1M | -64.8% |
| EPS (Basic) | $0.28 | -62.7% |
| EPS (Diluted) | $0.28 | -59.4% |
| Line Item | 2026-02-01 | Y/Y |
|---|---|---|
| Cash & Equivalents | $101.9M | +21.6% |
| Accounts Receivable | $11.7M | -30.1% |
| Current Assets | $236.6M | -4.0% |
| Total Assets | $534.7M | +0.5% |
| Current Liabilities | $147.1M | -5.2% |
| Total Liabilities | $316.0M | +0.0% |
| Stockholders' Equity | $218.7M | +1.1% |
| Line Item | 2026-02-01 | Y/Y |
|---|---|---|
| Operating Cash Flow | $49.3M | +26.6% |
| Capital Expenditures | $23.1M | +10.0% |
| Investing Cash Flow | -$24.0M | -11.6% |
| Financing Cash Flow | -$7.2M | +65.4% |
| Free Cash Flow | $26.2M | +45.9% |